Skip to main content

Tracon Pharmaceuticals, Inc.

TCONDelisted Jul 19, 2024
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001394319

Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.

13F holders, Q3 2021

Institutional positions in Tracon Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
45
+3 vs. Q2 2021
Shares held
10.2M
+1.34M (+15.1%) vs. Q2 2021
Total value
$39.6M
−$18.1M (−31.4%) vs. Q2 2021
New holders
9
11 more added
Sold out
6
11 more reduced

2 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TCON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 45 institutions
Q1 2021: 42 institutionsQ2 2021: 44 institutionsQ3 2021: 45 institutionsQ4 2021: 35 institutionsQ1 2022: 35 institutionsQ2 2022: 31 institutionsQ3 2022: 33 institutionsQ4 2022: 32 institutionsQ1 2023: 32 institutionsQ2 2023: 27 institutionsQ3 2023: 21 institutionsQ4 2023: 24 institutionsQ1 2024: 29 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2021: $39.6M
Q1 2021: $72.8MQ2 2021: $58.5MQ3 2021: $39.6MQ4 2021: $25.4MQ1 2022: $24.0MQ2 2022: $19.7MQ3 2022: $16.5MQ4 2022: $14.6MQ1 2023: $18.8MQ2 2023: $2.90MQ3 2023: $1.66MQ4 2023: $903.4KQ1 2024: $1.39MQ2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding TCON and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 202429$1.39M
Q4 202324$903.4K
Q3 202321$1.66M
Q2 202327$2.90M
Q1 202332$18.8M
Q4 202232$14.6M
Q3 202233$16.5M
Q2 202231$19.7M
Q1 202235$24.0M
Q4 202135$25.4M
Q3 202145$39.6M
Q2 202144$58.5M
Q1 202142$72.8M

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Tracon Pharmaceuticals, Inc.; share changes are against Q2 2021.

Institutions holding TCON in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Ikarian Capital, LLC2,691,110$10.4M2.38%−25,730−0.9%Reduced
Opaleye Management Inc.2,518,371$9.75M1.82%00.0%Unchanged
Altium Capital Management LP785,341$3.04M0.81%+785,341New
Vanguard Group Inc694,859$2.69M0.00%+5,821+0.8%Added
Two Sigma Advisers, LP367,800$1.42M0.00%+83,700+29.5%Added
NEA Management Company, LLC346,718$1.34M0.02%00.0%Unchanged
Two Sigma Investments, LP319,775$1.24M0.00%+69,716+27.9%Added
Renaissance Technologies LLC306,976$1.19M0.00%+133,441+76.9%Added
BlackRock Inc.299,283$1.16M0.00%+5,055+1.7%Added
Linden Advisors LP284,248$1.10M0.01%00.0%Unchanged
Boothbay Fund Management, LLC268,301$1.04M0.04%−25,730−8.8%Reduced
Geode Capital Management, LLC145,745$564.0K0.00%+7,923+5.7%Added
Psagot Investment House Ltd.143,591$556.0K0.10%+143,591New
Psagot Value Holdings Ltd. / (Israel)143,591$556.0K0.10%+143,591New
Millennium Management LLC139,477$540.0K0.00%+139,477New
Telemetry Investments, L.L.C.130,500$505.0K0.69%+90,500+226.3%Added
Gsa Capital Partners LLP85,993$333.0K0.03%+49,623+136.4%Added
Bank of New York Mellon Corp85,079$330.0K0.00%00.0%Unchanged
Johnson & Johnson84,003$325.0K0.03%+84,003New
State Street Corp72,954$282.0K0.00%00.0%Unchanged
Franklin Resources Inc43,700$169.0K0.00%+43,700New
Dowling & Yahnke LLC40,455$157.0K0.01%00.0%Unchanged
Citadel Advisors LLC36,466$141.0K0.00%+23,204+175.0%Added
ACT Capital Management, LLC28,500$110.0K0.06%00.0%Unchanged
Morgan Stanley24,704$96.0K0.00%+13,177+114.3%Added
Dimensional Fund Advisors LP22,595$87.0K0.00%−34,740−60.6%Reduced
X-Square Capital, LLC17,973$70.0K0.04%−3,000−14.3%Reduced
Northern Trust Corp17,337$67.0K0.00%00.0%Unchanged
CSS LLC14,900$58.0K0.00%00.0%Unchanged
Virtu Financial LLC14,938$58.0K0.01%+14,938New
Acadian Asset Management LLC14,072$53.0K0.00%−19,413−58.0%Reduced
Hoylecohen, LLC13,000$50.0K0.00%00.0%Unchanged
We Are One Seven, LLC11,780$44.0K0.01%00.0%Unchanged
Goldman Sachs Group Inc10,755$42.0K0.00%+10,755New
Lindbrook Capital, LLC2,000$8.00K0.00%−1,000−33.3%Reduced
Wells Fargo & Company1,330$5.00K0.00%−7,429−84.8%Reduced
Cutler Group LP1,200$4.00K0.00%00.0%Unchanged
Bank of America Corp739$3.00K0.00%+599+427.9%Added
Tower Research Capital LLC (TRC)445$2.00K0.00%+445New
Deutsche Bank AG131$1.00K0.00%−253,486−99.9%Reduced
JPMorgan Chase & Co223$1.00K0.00%−8,749−97.5%Reduced
Truvestments Capital LLC318$1.00K0.00%00.0%Unchanged
TCI Wealth Advisors, Inc.200$1.00K0.00%00.0%Unchanged
UBS Group AG85$00.00%−2,105−96.1%Reduced
O'Shaughnessy Asset Management, LLC54$00.00%−128−70.3%Reduced
Marshall Wace, LLP0$00.00%−56,351−100.0%Sold out
Susquehanna Fundamental Investments, LLC0$00.00%−31,616−100.0%Sold out
Price T Rowe Associates Inc0$00.00%−17,400−100.0%Sold out
Vigilare Wealth Management0$00.00%−17,000−100.0%Sold out
Advisory Services Network, LLC0$00.00%−1,000−100.0%Sold out
Group One Trading, L.P.0$00.00%−800−100.0%Sold out
Johnson & Johnson Innovation - JJDC, Inc.––––Not filed
QS Investors, LLC––––Not filed